Evaluation of PD-L1 (E1L3N, 22C3) expression in venous tumor thrombus is superior to its assessment in renal tumor in predicting overall survival in renal cell carcinoma-Reference-Cited by-同舟云学术

Evaluation of PD-L1 (E1L3N, 22C3) expression in venous tumor thrombus is superior to its assessment in renal tumor in predicting overall survival in renal cell carcinoma

Published:2022-05 Issue:5 Volume:40 Page:200.e1-200.e10
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Zapała Łukasz^ORCID,Kunc Michał,Sharma Sumit,Pęksa Rafał,Popęda Marta,Biernat Wojciech,Radziszewski Piotr

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference41 articles.

1. Clinical management of renal cell carcinoma with venous tumor thrombus;Agochukwu;World J Urol,2014

2. Immunogenic heterogeneity of renal cell carcinoma with venous tumor thrombus;Liss;Urology,2019

3. The role of neoadjuvant therapy in the management of locally advanced renal cell carcinoma;Borregales;Ther Adv Urol,2016

4. The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus;Cost;Eur Urol,2011

5. Neoadjuvant SABR for renal cell carcinoma inferior vena cava tumor thrombus-safety lead-in results of a phase 2 trial;Margulis;Int J Radiat Oncol Biol Phys,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving the prognostic accuracy in renal cell carcinoma with venous thrombus with novel predictive nomograms;Translational Andrology and Urology;2022-10

2. Immune checkpoint receptor VISTA on immune cells is associated with expression of T-cell exhaustion marker TOX and worse prognosis in renal cell carcinoma with venous tumor thrombus;Journal of Cancer Research and Clinical Oncology;2022-08-30